USPTO serial 76232602
PRESCIENT NEUROPHARMA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- IM, JEAN H
- Law office
- TMEG LAW OFFICE 101 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with PRESCIENT NEUROPHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Etobicoke Ontario, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Louis K. Ebling
LOUIS K EBLING GREENEBAUM DOLL & MCDONALD PLLC2800 CHEMED CTR255 E FIFTH STCINCINNATI, OH 45202Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Neurological disease therapeutic agents, namely, small molecules, proteins or conditioned media, for the treatment of neurological diseases; living cells which produce molecules to rescue and preserve nerve cells for scientific, laboratory or medical research use; bioassay system containing four phenotypes dopaminergic, GABAergic, serotonergic and cholinergic neurons, used to determine whether small molecules, proteins, and/or conditioned media from cells selectively prevent death of nerve cells | ACTIVE | — |
| 005 | Living cells which produce molecules to rescue and preserve nerve cells for medical use; pharmaceuticals for degenerative nerve diseases | ACTIVE | — |
| 040 | Custom manufacture of cell lines and molecules for others | ACTIVE | — |
| 042 | Biotechnology research and development services; providing access via license agreements to cell lines for research and development by others; bioassay services, namely, services to detect specific neurotrophic factors in clinical research | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Neurotrophic Bioscience Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named PRESCIENT NEUROPHARMA
- Prosecution event MAB2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 21, 2007 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 21, 2007 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 23, 2007 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jan 23, 2007 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Dec 18, 2006 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Dec 2, 2006 | ALIE | ASSIGNED TO LIE | — |
| May 13, 2006 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| May 12, 2006 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Oct 18, 2005 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Oct 7, 2005 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 28, 2005 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 28, 2005 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 5, 2005 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Apr 5, 2005 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Nov 24, 2004 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Apr 14, 2004 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 14, 2004 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 9, 2003 | CFIT | CASE FILE IN TICRS | — |
| Oct 21, 2003 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Nov 12, 2002 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 15, 2002 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Jan 28, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 26, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 12, 2001 | DOCK | ASSIGNED TO EXAMINER | — |